The major goal for prostate cancer imaging in the next decade is more accurate disease
characterization through the synthesis of anatomic, functional, and molecular imaging …

As prostate cancer is a biologically heterogeneous disease for which a variety of treatment
options are available, the major objective of prostate cancer imaging is to achieve more …

Imaging prostate cancer is a subject of controversy. The recommendations for imaging prior
to therapeutic selection range from denial to strong advocacy. Considering the …

The current diagnosis and management of prostate cancer is largely based on the use of
serum prostate-specific antigen (PSA) and pathologic risk factors such as Gleason score …

PURPOSE:: Staging for prostate cancer often includes bone scanning and computerized
tomography (CT). We systematically reviewed the published evidence for these tests …

Despite recent improvements in detection and treatment, prostate cancer continues to be the
most common malignancy and the second leading cause of cancer-related mortality. Thus …

In prostate cancer, bone is the second most common site of metastatic disease after lymph
nodes. This is related to a poor prognosis and is one of the major causes of morbidity and …

The bone scan continues to be recommended for both the staging and therapy response
assessment of skeletal metastases from prostate cancer. However, it is widely recognised …

Background The diagnosis of prostate cancer has long been plagued by the absence of an
imaging tool that reliably detects and localises significant tumours. Recent evidence …

CONTEXT: Although magnetic resonance imaging (MRI) is emerging as the most commonly
used imaging modality for prostate cancer (PCa) detection, treatment planning, and follow …